Halozyme Therapeutics Inc.

NASDAQ:HALO   3:59:50 PM EDT
35.55
+0.04 (+0.11%)
Other Pre-Announcement

Halozyme Therapeutics Sees FY Non-GAAP Earnings Per Share $2.05 To $2.20

Published: 01/10/2022 13:22 GMT
Halozyme Therapeutics Inc. (HALO) - Sees FY Non-GAAP Earnings per Share $2.05 to $2.20.
2022 Revenue Guidance of $530 to $560 Million.
Sees 2022 GAAP Diluted EPS of $1.90 to $2.05.
FY2022 Earnings per Share View $2.68, Revenue View $569.4 Million -- Refinitiv Ibes Data (analyst estimates).